Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar;38(3):923-8.
doi: 10.1007/s00726-009-0300-5. Epub 2009 May 20.

Plasma levels of nitric oxide related amino acids in demented subjects with Down syndrome are related to neopterin concentrations

Affiliations

Plasma levels of nitric oxide related amino acids in demented subjects with Down syndrome are related to neopterin concentrations

A M W Coppus et al. Amino Acids. 2010 Mar.

Abstract

Subjects with Down syndrome (DS) have abnormalities in virtually all aspects of the immune system and almost all will be affected with Alzheimer's disease (AD). It is thought that nitric oxide (NO) is involved in the pathophysiology of AD. In the present study, including a total of 401 elderly DS subjects, the spectrum of plasma amino acids and neopterin was investigated and related to development of AD. Concentrations of nearly all amino acids in DS subjects differed significantly from those of healthy controls. Neopterin was increased in DS subjects, especially in dementia. The production of NO as reflected by an increased citrulline/arginine ratio (Cit/Arg ratio) was enhanced during development of clinical dementia. Neopterin concentrations correlated to the Cit/Arg ratio only in the group of prevalent demented subjects (rho = 0.48, P = 0.006). The results of this study are suggestive for an increase in oxidative processes in DS subjects with AD.

PubMed Disclaimer

References

    1. Akomolafe A, Lunetta KL, Erlich PM, Cupples LA, Baldwin CT, Huyck M, Green RC, Farrer LA. Genetic association between endothelial nitric oxide synthase and Alzheimer disease. Clin Genet. 2006;1(70):49–56. doi: 10.1111/j.1399-0004.2006.00638.x. - DOI - PubMed
    1. Akyol O, Zoroglu SS, Armutcu F, Sahin S, Gurel A. Nitric oxide as a physiopathological factor in neuropsychiatric disorders. In Vivo. 2004;3(18):377–390. - PubMed
    1. Aylward EH, Burt DB, Thorpe LU, Lai F, Dalton A. Diagnosis of dementia in individuals with intellectual disability. J Intellect Disabil Res. 1997;41(Pt 2):152–164. doi: 10.1111/j.1365-2788.1997.tb00692.x. - DOI - PubMed
    1. Bernstein HG, Heinemann A, Krell D, Dobrowolny H, Bielau H, Keilhoff G, Bogerts B. Hypothalamic nitric oxide synthase in affective disorder: focus on the suprachiasmatic nucleus. Cell Mol Biol (Noisy-le-grand) 2005;3(51):279–284. - PubMed
    1. Burt DB, Aylward EH. Test battery for the diagnosis of dementia in individuals with intellectual disability: working group for the establishment of criteria for the diagnosis of dementia in individuals with intellectual disability. J Intellect Disabil Res. 2000;44(Pt 2):175–180. doi: 10.1046/j.1365-2788.2000.00264.x. - DOI - PubMed

Publication types

MeSH terms